Patents Assigned to Alellyx S.A.
  • Publication number: 20130133113
    Abstract: The present invention relates to nucleic acid molecules corresponding to regulatory portions of genes whose expression is constitutive. The invention also relates to compositions and methods of using the same to regulate the expression, in a constitutive manner, of genes and/or any kind of nucleotide sequences in a plant. Nucleic acid molecules and its compositions include novel nucleotide sequences for constitutive promoter identified in and isolated from poplar (Populus spp). Methods for expressing genes and/or any kind of nucleotide sequences in a plant using the promoter sequences disclosed herein are provided. The methods comprise stably incorporating into the genome of a plant cell a nucleotide sequence operably linked to one or more of the constitutive promoters of the present invention and regenerating a stably transformed plant that expresses the nucleotide sequence.
    Type: Application
    Filed: December 13, 2012
    Publication date: May 23, 2013
    Applicant: Alellyx S.A.
    Inventor: Alellyx S.A.
  • Patent number: 8420796
    Abstract: The present invention relates to nucleic acid molecules corresponding to regulatory portions of genes whose expression is constitutive. The invention also relates to compositions and methods of using the same to regulate the expression, in a constitutive manner, of genes and/or any kind of nucleotide sequences in a plant. Nucleic acid molecules and its compositions include novel nucleotide sequences for constitutive promoter identified in and isolated from poplar (Populus spp). Methods for expressing genes and/or any kind of nucleotide sequences in a plant using the promoter sequences disclosed herein are provided. The methods comprise stably incorporating into the genome of a plant cell a nucleotide sequence operably linked to one or more of the constitutive promoters of the present invention and regenerating a stably transformed plant that expresses the nucleotide sequence.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: April 16, 2013
    Assignee: Alellyx S.A.
    Inventors: Fabio Papes, Paulo Arruda
  • Patent number: 7943339
    Abstract: Disclosed are nucleic acids from the Citrus Leprosis Virus (CiLV) genome, associated with Citrus Leprosis (CiL) disease. Cloned CiLV nucleic acids can be used as probes or primers in assays for detecting CiLV in biological samples, particularly leaves, roots and other tissues of plants, such as plants from Citrus and Poncirus. The nucleic acid molecules can be introduced in cloning vectors and cloning the recombinant nucleic acid molecules in cells, such as prokaryotes, and eukaryotes. The cloned CiLV nucleic acids are expressed in cells to provide immunogenic proteins which can be used to raise antibodies against CiLV, which can then be used to detect CiLV virus in biological samples. Also disclosed are SEQ ID Nos. 5 and 8, in whole or part, transgenic plants, such as monocots and dicots, containing CiLV nucleic acids, in any combination, so that expression increases resistance to CiL disease.
    Type: Grant
    Filed: September 6, 2005
    Date of Patent: May 17, 2011
    Assignee: Alellyx S.A.
    Inventors: Renata Castiglioni Pascon, Ana Claudia Rasera Silva
  • Publication number: 20090229016
    Abstract: The present invention related to nucleic acid molecules corresponding to regulatory portions of genes whose expression is predominant in cambium and/or xylem. The invention also relates to compositions and methods of using the same to regulate the expression, in a cambium/xylem-preferred manner, of genes and/or any kind of nucleotide sequences in a plant. Nucleic acid molecules and its compositions include novel nucleotide sequences for cambium/xylem-preferred promoters identified and isolated from poplar (Populus spp). Methods for expressing genes and/or any kind of nucleotide sequences in a plant using the promoter sequences disclosed herein are provided. The methods comprise stably incorporating into the genome of a plant cell a nucleotide sequence operably linked to a cambium/xylem-preferred promoter of the present invention and regenerating a stably transformed plant that expresses the nucleotide sequence.
    Type: Application
    Filed: June 13, 2007
    Publication date: September 10, 2009
    Applicant: ALELLYX S.A.
    Inventors: Fabio Papes, Isabel Gerhardt, Paulo Arruda